FINWIRES · TerminalLIVE
FINWIRES

CGN Power Completes Taishan Unit Two Overhaul

By

CGN Power (SHE:003816, HKG:1816) said the Taishan Unit Two completed its annual refueling overhaul and resumed grid connection on Tuesday.

The overhaul, which began in late 2025 at the Taishan Nuclear Power Station, included additional inspections and tests to support long-term operational stability, according to a Wednesday filing with the Shenzhen bourse.

Shares of the power supplier were down 2% in recent trade on the Shenzhen bourse.

Related Articles

Asia

SK Reit to Lease SK Seorin Building in Seoul to SK Inc

SK Reit (KRX:395400) signed a five-year lease agreement for its SK Seorin Building in Seoul with SK Inc (KRX:034730) with an aim to generate rental income, according to a Tuesday filing with the Korea Exchange.The building has an annual rent of 52.8 billion won, with the lease running from July 2026 to July 2031. The transaction value of the deal stood at 53.8 billion won, which included a 32.7 billion won security deposit, the filing said.

$KRX:034730$KRX:395400
Asia

Sky Metals Progresses New South Wales Project Through State's Approvals Process

Sky Metals (ASX:SKY) said the New South Wales Department of Planning, Housing and Infrastructure issued environmental assessment requirements for the company's Tallebung tin-silver-tungsten project, according to a Wednesday filing with the Australian bourse.The issuance marks "a significant development milestone" for the project, which is now advancing into the environmental impact statement phase of the state government's approvals process, the company said.Sky Metals said an updated mineral resource estimate and pre‑feasibility study are on track for release in the coming weeks.The company's shares fell 2% in recent Wednesday trade.

$ASX:SKY
Asia

Mankind Pharma Arm Acquires Remaining 10% Stake in Upakarma Ayurveda

Mankind Lifesciences, a wholly-owned subsidiary of Mankind Pharma (NSE:MANKIND, BOM:543904), has acquired the remaining 10% stake it did not already own in Upakarma Ayurveda for 7.50 million Indian rupees, according to a Tuesday filing to the Indian stock exchanges.Mankind Lifesciences already held 90% stake in Upakarma Ayurveda, and has acquired the remaining 10% stake of Upakarma from Kaushcorp Media.Following the acquisition, Upakarma has become a wholly-owned subsidiary of Mankind Lifesciences and a step-down subsidiary of the company.Upakarma sells ayurvedic, herbal, and nutraceutical products.

$BOM:543904$NSE:MANKIND